Article
Published 17 Oct 2025
The PBM Effect: Regulatory And Market Implications For Life Sciences Companies And Healthcare Providers
Buchanan Ingersoll & Rooney PC
Your search returned 6,479 results
Refine Your Search
Search Results
- Relevance
- Newest
- Oldest
Article
Published 16 Oct 2025
Amgen And Biocon Settle Denosumab BPCIA Case
Goodwin Procter LLP
Article
Published 16 Oct 2025
FDA Approves Celltrion's Aflibercept Biosimilar
Goodwin Procter LLP
Article
Published 16 Oct 2025
Ohio's PBM Regulation Passed By House Of Representatives
Buchanan Ingersoll & Rooney PC
Article
Published 15 Oct 2025
The New (And Politically Improved?) BIOSECURE Act
Mintz
Article
Published 15 Oct 2025
FDCA: Fifth Circuit End-Run Suggests State Law Private Right Of Action
Foley & Lardner
Article
Published 14 Oct 2025
Advances In Plant Biotechnology Improving Health And Well-Being
J A Kemp LLP
Article
Published 14 Oct 2025
BIOSECURE Included In Draft National Defense Authorization Act Of 2026
Goodwin Procter LLP
Article
Published 14 Oct 2025
EPO To Allow Color And Greyscale Patent Drawings: What U.S. Companies Need To Know
Barnes & Thornburg LLP
Article
Published 14 Oct 2025
Celltrion Announces Launch Of AVTOZMA® (Tocilizumab-anoh) Intravenous Formulation In The United States
Goodwin Procter LLP
Article
Published 14 Oct 2025
Connecting Innovators In Life Sciences With Jennifer Hawks Bland (Podcast)
Crowley Law LLC
Article
Published 13 Oct 2025
Kashiv BioSciences Omalizumab Biosimilar Application Submitted To FDA, Accepted By EMA
Goodwin Procter LLP
Article
Published 9 Oct 2025
Biogen Ordered To Pay Genentech $88.3 Million In Past Royalties On Cabilly Patents
Goodwin Procter LLP
Article
Published 8 Oct 2025
Aflibercept BPCIA Multi-District Litigation Updates
Goodwin Procter LLP
Article
Published 8 Oct 2025
The Continued Rise Of Royalty Deals In Life Sciences
Goodwin Procter LLP
Article
Published 8 Oct 2025
Key Considerations For Food Safety Recalls
Steptoe LLP
Article
Published 8 Oct 2025
FDA Seeks Stakeholder Feedback On AI-Enabled Medical Device Performance
Katten Muchin Rosenman LLP
Video
Published 8 Oct 2025
Non-binding Guidance: The Administration's Focus On Direct-to-Consumer Prescription Drug Advertising (Podcast)
Ropes & Gray LLP
Article
Published 8 Oct 2025
FDA Seeks Input On Real-World Performance Of AI-Enabled Medical Devices: What Biotech And MedTech Innovators Need To Know
Crowell & Moring LLP
Podcast
Published 7 Oct 2025
Podcast - Part I: Going From Young Associate To Veteran Lawyer
Holland & Knight